Both molecules reported an interesting inhibitory effect in the aggregation of amyloid β (Aβ) and Tau proteins, which are involved in AD [280,281], by disrupting the pre-formed Tau fibril and blocking the Tau–Tau interaction [282]. Here, MAPT is linked to Alzheimer disease.